CompoAtlas

Détoxi-foie

Food supplement declared in France, declaration No 2021-5-1236

Détoxi-foie is a food supplement declared in France. Status: retiré du marché le 30 October 2026. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
HERA PLANTES
Status
Retiré du marché le 30 October 2026
Form
Gélule
Daily dose
3 gélules
Directions for use
3 gélules par jour
Not recommended for (according to the manufacturer)
Femmes allaitantes, Femmes enceintes, Sous antidiabétiques, Sous traitement pour la thyroïde

Declaration 313463, procedure Article 16. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.

Regulatory points

Declared composition

Plants

PlantPartPreparationPer day
Cynara scolymus L.FeuilleExtrait sec aqueux201 mg
Peumus boldus MolinaFeuilleExtrait sec aqueux201 mg
Silybum marianum (L.) Gaertn.GraineExtrait sec alcoolique201 mg
Combretum micranthum G.DonFeuilleExtrait sec aqueux201 mg
Desmodium adscendens (Sw.) DC.FeuilleExtrait sec hydroalcoolique201 mg
Raphanus raphanistrum subsp. sativus (L.) DominRacineExtrait sec hydroalcoolique150 mg

Other active ingredients

NamePer day
Bétaïnenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
Acide ptéroylmonoglutamiqueFolates (vitamine B9)1,000 µg200 µg
MéthylcobalamineVitamine B12pas d'effet indésirable définidose annulée par le Conseil d'État en 2011

Additives

E470b

Other ingredients

Gélule végétale

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Déconseillé chez les femmes enceintes et allaitantes, et les personnes sous traitement antidiabétique. Les personnes ayant une hypothyroïdie ou un traitement de la thyroïde doivent préalablement consulter un professionnel de santé.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Enter to analyse, Shift+Enter for a new line